Local therapies for advanced prostate cancer were associated with significantly more gastrointestinal and sexual issues in subsequent years than systemic treatments.
Adding higher dose radiation led to long-term ADT led to better progression-free, cancer-specific, and overall survival vs standard-dose radiation in men with high-risk prostate cancer.